AGTC stock forecast
Our latest prediction for Applied Genetic Technologies Corp.'s stock price was made on the Dec. 14, 2018 when the stock price was at 3.25$.
In the short term (2weeks), AGTC's stock price should outperform the market by 5.32%. During that period the price should oscillate between -8.72% and +19.84%.
In the medium term (3months), AGTC's stock price should outperform the market by 4.85%. During that period the price should oscillate between -18.49% and +42.90%.Get email alerts
Create a solid portfolio with AGTC
About Applied Genetic Technologies Corp.
Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.
At the moment the company generates 28M USD in revenues.
On its last earning announcement, the company reported a loss of -0.82$ per share.
The book value per share is 5.47$
Three months stock forecastDec. 14, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|